The SEREX method has been applied to many types of cancers and has resulted in the identification of several tumor antigens including p53 antigens, and in fact, serum p53 antibodies serve as tumor markers for multiple types of cancers such as esophageal, colon, and lung cancers [11–17]. This evidence concerns the gene TP53 and lung cancer.